Financings in Brief: Conceptus
This article was originally published in The Gray Sheet
Executive Summary
Conceptus: Files registration statement with the Securities and Exchange Commission for an initial public offering of 2.5 mil. shares. San Carlos, California-based Conceptus, a developer and manufacturer of devices for reproductive applications, is focused initially on devices for "improving the diagnosis and treatment of fallopian tube diseases and disorders." The firm anticipates selling its shares for $11 to $13 each. Proceeds from the IPO will be used to "fund clinical trials, research and development activities, expansion of marketing and sales activities," as well as for "working capital and other general corporate activities," the company says. UBS Securities and Piper Jaffray are underwriting...